Back to Search Start Over

Pharmacodynamic mechanism-based interaction model for the haemodynamic effects of remifentanil and propofol in healthy volunteers.

Authors :
Su H
Koomen JV
Eleveld DJ
Struys MMRF
Colin PJ
Source :
British journal of anaesthesia [Br J Anaesth] 2023 Aug; Vol. 131 (2), pp. 222-233. Date of Electronic Publication: 2023 Jun 22.
Publication Year :
2023

Abstract

Background: Propofol and remifentanil are frequently combined for the induction and maintenance of general anaesthesia. Both propofol and remifentanil cause vasodilation and potentially reduce arterial BP. We aimed to develop a mechanism-based model that characterises the haemodynamic interactions between remifentanil and propofol.<br />Methods: Data from two clinical trials in healthy volunteers were analysed using remifentanil-alone, propofol-alone, and combination groups. We evaluated remifentanil effects on haemodynamics using a previously developed mechanism-based haemodynamic model of propofol. The interaction between propofol and remifentanil was explored using the principles of the general pharmacodynamic interaction (GPDI) model.<br />Results: Remifentanil alone increased the dissipation rate of total peripheral resistance by 50% at 3.0 ng ml <superscript>-1</superscript> . Additionally, the dissipation rates of HR and stroke volume were attenuated by 4.8% and 4.9% per 1 ng ml <superscript>-1</superscript> increase in remifentanil concentration, respectively. The maximal effect of propofol alone in decreasing the production rate of total peripheral resistance was 78%, which decreased to 32% when combined with remifentanil 4 ng ml <superscript>-1</superscript> . The effects of remifentanil on HR and stroke volume were attenuated by propofol with maximum decreases of 11.9% and 21.2%, respectively. Goodness-of-fit plots and prediction-corrected visual predictive check plots showed good predictive performance of the models.<br />Conclusions: The structure of the previous mechanism-based haemodynamic model for propofol was able to describe the effects of remifentanil alone on haemodynamic variables. The GPDI model provided a good framework for characterising the pharmacodynamic interaction between remifentanil and propofol on haemodynamic properties.<br />Clinical Trial Registration: NCT02043938; NCT03143972.<br /> (Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.)

Details

Language :
English
ISSN :
1471-6771
Volume :
131
Issue :
2
Database :
MEDLINE
Journal :
British journal of anaesthesia
Publication Type :
Academic Journal
Accession number :
37355412
Full Text :
https://doi.org/10.1016/j.bja.2023.04.043